EFFECTS OF COMBINING CARBIDOPA WITH LEVODOPA FOR PARKINSONS-DISEASE

被引：0

作者：

MARTIN, WE ^{[1
]}

TOLOSA, ES ^{[1
]}

LOEWENSON, RB ^{[1
]}

LEE, MC ^{[1
]}

RESCH, JA ^{[1
]}

BAKER, AB ^{[1
]}

机构：

[1] UNIV MINNESOTA,HLTH SCI CTR,DEPT NEUROL,MINNEAPOLIS,MN 55455

来源：

GERIATRICS | 1975年 / 30卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

引用

页码：39 / 44

页数：6

共 20 条

[1]

BARBEAU A, 1969, CAN MED ASSOC J, V101, P791

[2]

Barbeau A., 1973, TREATMENT PARKINSONI, P173

[3] IDIOPATHIC PARKINSONISM TREATED WITH AN EXTRACEREBRAL DECARBOXYLASE INHIBITOR IN COMBINATION WITH LEVODOPA [J].

CALNE, DB ;

REID, JL ;

VAKIL, SD ;

RAO, S ;

PETRIE, A ;

PALLIS, CA ;

GAWLER, J ;

THOMAS, PK ;

HILSON, A .

BRITISH MEDICAL JOURNAL, 1971, 3 (5777) :729-&

[4]

CANTER GJ, 1961, J NERV MENT DIS, V122, P143

[5] METHYLDOPAHYDRAZINE AS AN ADJUNCT TO L-DOPA THERAPY IN PARKINSONISM [J].

CHASE, TN ;

WATANABE, AM .

NEUROLOGY, 1972, 22 (04) :384-&

[6] MODIFICATION OF PARKINSONISM - CHRONIC TREATMENT WITH L-DOPA [J].

COTZIAS, GC ;

PAPAVASI.PS ;

GELLENE, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (07) :337-&

[7] METABOLISM OF 3,4-DIHYDROXYPHENYLALANINE (L-DOPA) IN HUMAN SUBJECTS [J].

GOODALL, MC ;

ALTON, H .

BIOCHEMICAL PHARMACOLOGY, 1972, 21 (17) :2401-+

[8] PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].

HOEHN, MM ;

YAHR, MD .

NEUROLOGY, 1967, 17 (05) :427-&

[9]

HORNYKIE.O, 1973, FED PROC, V32, P183

[10] MECHANISMS OF ACTION OF L-DOPA IN PARKINSONS-DISEASE [J].

HORNYKIEWICZ, O .

LIFE SCIENCES, 1974, 15 (07) :1249-1259

← 1 2 →